ArticleInternational journal of hematology2019

Addition of melphalan to fludarabine/busulfan (FLU/BU4/MEL) provides survival benefit for patients with myeloid malignancy following allogeneic bone-marrow transplantation/peripheral blood stem-cell transplantation.

Tomoaki Ueda et al.PubMed ↗Publisher ↗

No numbers read from the abstract.